BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34763650)

  • 1. Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
    Djuzenova CS; Fischer T; Katzer A; Sisario D; Korsa T; Steussloff G; Sukhorukov VL; Flentje M
    BMC Cancer; 2021 Nov; 21(1):1201. PubMed ID: 34763650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.
    Djuzenova CS; Fiedler V; Memmel S; Katzer A; Sisario D; Brosch PK; Göhrung A; Frister S; Zimmermann H; Flentje M; Sukhorukov VL
    BMC Cancer; 2019 Apr; 19(1):299. PubMed ID: 30943918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.
    Djuzenova CS; Fiedler V; Katzer A; Michel K; Deckert S; Zimmermann H; Sukhorukov VL; Flentje M
    Oncotarget; 2016 Jun; 7(25):38191-38209. PubMed ID: 27224913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-dependent protein kinase (DNA-PK)-deficient human glioblastoma cells are preferentially sensitized by Zebularine.
    Meador JA; Su Y; Ravanat JL; Balajee AS
    Carcinogenesis; 2010 Feb; 31(2):184-91. PubMed ID: 19933707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair.
    Westhoff MA; Kandenwein JA; Karl S; Vellanki SH; Braun V; Eramo A; Antoniadis G; Debatin KM; Fulda S
    Oncogene; 2009 Oct; 28(40):3586-96. PubMed ID: 19633683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
    Memmel S; Sisario D; Zöller C; Fiedler V; Katzer A; Heiden R; Becker N; Eing L; Ferreira FLR; Zimmermann H; Sauer M; Flentje M; Sukhorukov VL; Djuzenova CS
    Oncotarget; 2017 Jul; 8(28):45298-45310. PubMed ID: 28424411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells.
    Pastwa E; Poplawski T; Lewandowska U; Somiari SB; Blasiak J; Somiari RI
    Int J Biochem Cell Biol; 2014 Aug; 53():423-31. PubMed ID: 24953561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The repair of gamma-radiation-induced DNA damage is inhibited by microcystin-LR, the PP1 and PP2A phosphatase inhibitor.
    Lankoff A; Bialczyk J; Dziga D; Carmichael WW; Gradzka I; Lisowska H; Kuszewski T; Gozdz S; Piorun I; Wojcik A
    Mutagenesis; 2006 Jan; 21(1):83-90. PubMed ID: 16434448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.
    Azad A; Jackson S; Cullinane C; Natoli A; Neilsen PM; Callen DF; Maira SM; Hackl W; McArthur GA; Solomon B
    Mol Cancer Res; 2011 Dec; 9(12):1696-707. PubMed ID: 22009179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of interferon beta-induced radiosensitization in four out of five human glioblastoma cell lines.
    Schmidberger H; Rave-Fränk M; Lehmann J J; Weiss E; Gerl L; Dettmer N; Glomme S; Hess CF
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1348-57. PubMed ID: 12654447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
    Kuger S; Flentje M; Djuzenova CS
    Radiat Oncol; 2015 Oct; 10():214. PubMed ID: 26498922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA-PKcs and telomerase in brain tumour cells.
    Gurung RL; Lim HK; Venkatesan S; Lee PS; Hande MP
    Mol Cancer; 2014 Oct; 13():232. PubMed ID: 25307264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
    Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
    Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
    Klieber N; Hildebrand LS; Faulhaber E; Symank J; Häck N; Härtl A; Fietkau R; Distel LV
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
    Gustafsson AS; Abramenkovs A; Stenerlöw B
    Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    Ströbele S; Schneider M; Schneele L; Siegelin MD; Nonnenmacher L; Zhou S; Karpel-Massler G; Westhoff MA; Halatsch ME; Debatin KM
    PLoS One; 2015; 10(6):e0131670. PubMed ID: 26121251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2014 Oct; 5(10):e1437. PubMed ID: 25275598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
    BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.